维普期刊资源整合服务平台（V6.5）

134篇 您的检索式：作者名="Recke J"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Bubble size estimation for flotation processes显示文摘	Lin B Recke B Knudsen J K H	2008	Minerals Engineering2008，21，7：	1
2	Phase III trial of cispl-atin plus gemcitabine with either placebo or bevacizumab asfirst-line therapy for nonsquamous non-small-cell lung cancer:Avail显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
3	Final safety results of BO17704(A-VAiL):a phase III randomized study of first-line bevacizumab(BV)and cisplatin/gemcitabine(CG)in patients(pts)with ad-vanced or recurrent nonsquamous non-small cell lung cancer(NSCLC)显示文摘	Hirsh V Ramlau R von Pawel J Zatloukal P Vera G Leighl N Mezger J Archer V Reck M	2009	J Clin Oncol2009，，：	1
4	The energy benefit of stainless steel recycling 显示文摘	JOHNSON J RECK B K WANG T GRAEDEL T E	2008	Energy Policy2008，36，1：	1
5	PhaseⅢtrial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-smallcell lung cancer:AVAil显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
6	Overall survival with cispl- atin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAIL)显示文摘	Reck M yon Pawel J Zatloukal P	2010	Ann Oncol2010，21，9：	1
7	PhaseⅢ trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer:AVAil显示文摘	Reck M von Pawel J Zatloukal P		0，，：	1
8	Enterprise resource planning systems:comparing firm performance of adopters and nonadopters显示文摘	Hunton J E Lippincott B Reck J L	2003	International Journal of Accounting Information Systems2003，，4：	1
9	Phase El trial of cispl-atin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
10	Phase III trial of eisplatin plus gemcitabine with either placebo or bevaeizumab as firstline therapy for nonsquamous non-small-cell lung cancer: AVAil 显示文摘	Reck M yon Pawel J Zatloukl P	2009	J ClinOncol2009，27，8：	1
11	Phase Ⅲ trial of cisplatine plus gemcitabine with either placebo or bevaci- zumab as first-line therapy for nonsquamons non-small- cell lung cancer显示文摘	Reck M von Rawel J Zatlonkal P	2009	AVAil J Clin Onc2009，27，8：	1
12	Bubble size estimation for flotation processes显示文摘	LIN Bao RECKE B KNUDSEN J K H	2008	Minerals Engineering2008，21，7：	1
13	Carboplatin/paclitaxelwith/without sorafenib in chemonaive patients with stage IIIB/IV non-small cell lung cancer(NSCLC):Interim analysis(IA)results from a randomized phase III trial(ESCAPE)显示文摘	Hanna N Von Pawel J Reck M	2008	J Tho-rac Oncol2008，3，26：	1
14	Porcine circovirus 2 (PCV2) induces a procoagulant state in naturally infected swine and in cultured endothelial cells显示文摘	Marks F S Reck J Jr Almeida L L	2009	Vet Microbiol2009，143，：	1
15	A Systematic Approach for Soft Sensor Development显示文摘	LIN B RECKE B KNUDSEN J K H	2007	Computers and Chemical Engineering2007，31，05：	1
16	Reversible digital and holographic optical storage in polymeric liquid crystals 显示文摘	Eich M Wendroff J H Reck B	1987	Makromol Chem Rapid Commun1987，8，：	1
17	The usefulness of financial and nonfinancial performance information in resource allocation decisions显示文摘	RECK J L	2001	Journal of Accounting and Public Policy2001，20，1：	1
18	Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil显示文摘	Reck M von Pawel J Zatloukal P	2009	J Clin Oncol2009，27，8：	1
19	Phase Ill trial of cisplatin plus gemcitabine with either placebo bevacizumab as first - line therapy fi)r non - squamous non - small - cell lung cancer 显示文摘	Reck M yon Pawel J Zadoukal B	2009	J Clin Oncol2009，，27：	1
20	Calcium absorbability from milk products, an imitation milk and calcium carbonate显示文摘	RECKE R BAMNI A BARGER-LUX M J	1988	J Clini Nutr1988，47，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示